Back to top
more

AmerisourceBergen Corporation (ABC)

(Delayed Data from NYSE)

$79.14 USD

79.14
2,090,506

+2.08 (2.70%)

Updated May 3, 2019 04:01 PM ET

After-Market: $79.11 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

by Zacks Equity Research

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

AmerisourceBergen (ABC) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

AmerisourceBergen (ABC) closed the most recent trading day at $153.44, moving -1.67% from the previous trading session.

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

by Zacks Equity Research

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a concern.

AmerisourceBergen (ABC) Stock Moves -1.22%: What You Should Know

by Zacks Equity Research

AmerisourceBergen (ABC) closed at $150 in the latest trading session, marking a -1.22% move from the prior day.

Cooper Companies (COO) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Cooper Companies' (COO) first-quarter fiscal 2023 revenues reflect a solid segmental performance despite a year-over-year decline in earnings.

Patterson Companies (PDCO) Q3 Earnings Beat, Sales Hurt by FX

by Zacks Equity Research

Patterson Companies' (PDCO) fiscal third-quarter 2023 results are negatively impacted by unfavorable currency movements.

Inari Medical (NARI) Q4 Earnings Beat, Revenues Rise Y/Y

by Zacks Equity Research

Inari Medical's (NARI) fourth-quarter results benefit from significant progress made across all its growth drivers.

DENTSPLY SIRONA (XRAY) Q4 Earnings & Revenues Beat Estimates

by Zacks Equity Research

DENTSPLY SIRONA's (XRAY) Q4 earnings and revenues decline year over year due to unfavorable foreign currency movement and soft demand across all geographical segments.

3 Reasons Why Growth Investors Shouldn't Overlook AmerisourceBergen (ABC)

by Zacks Equity Research

AmerisourceBergen (ABC) possesses solid growth attributes, which could help it handily outperform the market.

Are Investors Undervaluing AmerisourceBergen (ABC) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Penumbra (PEN) Q4 Earnings Top Estimates, Sales Remain Robust

by Zacks Equity Research

Penumbra's (PEN) sales during the fourth quarter reflect continued demand for its products. The 2023 outlook is encouraging as EPS improves despite macro challenges.

Glaukos' (GKOS) Q4 Earnings Beat Estimates, Sales Decline Y/Y

by Zacks Equity Research

Glaukos' (GKOS) Q4 revenues beat estimates but fall year over year. Lower revenues, along with higher expenses, hurt margins.

Fresenius Medical's (FMS) Q4 Earnings and Revenues Beat

by Zacks Equity Research

Fresenius Medical's (FMS) fourth-quarter revenues benefit from strong performance across all segments, especially in the North America and Asia-Pacific regions. However, rising costs hurt margins.

3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.

Zacks.com featured highlights include Archer Daniels, Delek US Holdings, Beazer Homes USA, AmerisourceBergen and Avnet

by Zacks Equity Research

Archer Daniels, Delek US Holdings, Beazer Homes USA, AmerisourceBergen and Avnet are part of the Zacks Screen of the Week article.

Maharathi Basu headshot

5 Stocks to Keep an Eye on Following Upgrade by Brokers

by Maharathi Basu

We believe that broker-favorite stocks like Archer Daniels (ADM), Delek US (DK), Beazer Homes (BZH), AmerisourceBergen (ABC) and Avnet (AVT) are worth a look.

Should Value Investors Buy AmerisourceBergen (ABC) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Industry Outlook Highlights McKesson, AmerisourceBergen, LabCorp, Cardinal Health and Merit Medical

by Zacks Equity Research

McKesson, AmerisourceBergen, LabCorp, Cardinal Health and Merit Medical have been highlighted in this Industry Outlook article.

Here's Why AmerisourceBergen (ABC) is a Strong Value Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Indrajit Bandyopadhyay headshot

5 Dental Supplies Stocks to Buy Amid Recovering Prospects

by Indrajit Bandyopadhyay

Here, we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors - MCK, ABC, LH, CAH and MMSI.

AmerisourceBergen (ABC) Q1 Earnings Top, EPS View Raised

by Zacks Equity Research

AmerisourceBergen's (ABC) fiscal first-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin.

AmerisourceBergen (ABC) Surpasses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

AmerisourceBergen (ABC) delivered earnings and revenue surprises of 3.44% and 0.93%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

AmerisourceBergen (ABC) to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

AmerisourceBergen's (ABC) fiscal first-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.

Becton Dickinson (BDX) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.